Index
Module 18 • Pulmonology
Pulmonary Disorders I
59%
Data Tables
Pulmonary Disorders I
Grace E. Benanti ~3 min read Module 18 of 20
17
/ 29

Pulmonary Disorders I

D.Pretreatment or Preintubation Optimization
1

Occurs before an induction agent or NMBA is administered

2Pretreatment attenuates the sympathetic and parasympathetic responses (catecholamine release,

hypertension, tachycardia, potentially increased ICP in patients with impaired cerebral autoregulation)

to laryngoscopy. However, because of low quality of evidence and lack of demonstration of benefit to the

patient, this step is more commonly omitted.

3

Fentanyl or lidocaine can be used as a pretreatment medication (Table 7).

4

Atropine and defasciculating doses of nondepolarizing NMBAs are not recommended for routine use in

RSI for adult patients.

5

More contemporarily, this step may be called β€œpreintubation optimization,” which involves stabilization

of hemodynamic parameters and creation of mitigation strategies for other possible complications (Am J

Health Syst Pharm. 2023;80(4):182-195).

Table 7. Pretreatment Agents

Agent

Dose

Onset

Duration

Advantages

Disadvantages

Fentanyl

IV: 1–3

mcg/kg

< 30 s

0.5–1 hr

β€’Blunts hypertensive response

from intubation

β€’Recommended over other

opioids because of its rapid

onset and short duration of

action

β€’Chest wall rigidity

(doses > 100 mcg/kg)

β€’Hypotension,

bradycardia, and

respiratory depression

Agent

Dose

Onset

Duration

Advantages

Disadvantages

Lidocaine

IV: 1.5

mg/kg

45–90 s

10–20 min

β€’May prevent increase in ICP

through blunting of cough

reflex

β€’May reduce bronchospasm in

patients with reactive airway

disease

β€’Contraindicated in

patients with an amide

anesthetic allergy,

bradycardia, or severe

heart block

ICP = intracranial pressure; IV = intravenous(ly).

E.Induction Agents
1

Given as rapid intravenous push immediately before the paralyzing agent to help achieve optimal

conditions for intubation

2Agents should provide rapid loss of consciousness, analgesia, amnesia, and stable hemodynamics.
3

Agents used for induction during RSI include barbiturates, benzodiazepines (midazolam), etomidate,

ketamine, and propofol (Table 8).

4

Barbiturates

Thiopental is no longer available in the United States.

Methohexital is rarely used because of its adverse effect profile, including respiratory depression,

hypotension, and histamine release.

5

Etomidate

A nonbarbiturate, imidazole derivative with a rapid onset of action and a very short elimination

half-life

Enhances the effects of Ξ³-aminobutyric acid, thereby blocking neuroexcitation and inducing

unconsciousness (does not provide analgesia)

Transiently inhibits the conversion of cholesterol to cortisol by inhibiting 11ß-hydroxylase, leading

to transient adrenal suppression

Ψ΄Ψ±Ψ­ Ψ§Ω„ΩΩŠΨ―ΩŠΩˆ Ψ§Ω„ΨͺΨΉΩ„ΩŠΩ…ΩŠ β€” Ω…Ψ²Ψ§Ω…Ω†Ψ© Ω…ΨΉ Ψ§Ω„Ω€ PDF
Ψ¨Ψ―Ψ‘ Ψ§Ω„ΨͺΨ΄ΨΊΩŠΩ„ Ω…Ω†: Ψ§Ω„Ψ―Ω‚ΩŠΩ‚Ψ© 16 فΨͺΨ­ ΨΉΩ„Ω‰ YouTube